Skip to main content
. 2022 Mar 9;13(6):1011–1020. doi: 10.1111/jdi.13750

Figure 5.

Figure 5

Comparison of the results of question C between 2016 and 2020 for each diabetologists or non‐diabetologists. In 2016 and 2020, diabetologists and non‐diabetologists chose first‐ and second‐line drugs from nine hypoglycemic agents for each of the six cases (C1–C6).